2m 2m 2m 2m 2m 2m 2m
DELCATH SYS (DCTH)
NASDAQ
$14.74+$0.04 (+0.27%)
Price as of Oct 22, 2026 7:30 PM EDT- $510.1MMarket Cap
- 41.89%1-Year Change
- Medical DevicesIndustry
DELCATH SYS (DCTH)
$14.74+$0.04 (+0.27%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
ROSALIND ADVISORS, INC. | 9.51% | 3.3M | 0 (0.00%) | Jun 30, 2026 |
BLACKROCK, INC. | 7.80% | 2.7M | +922,336 (+34.07%) | Jun 30, 2026 |
VANGUARD GROUP INC | 4.82% | 1.7M | +14,929 (+0.89%) | Dec 31, 2025 |
VANGUARD CAPITAL MANAGEMENT LLC | 3.52% | 1.2M | -108,041 (-8.85%) | Jun 30, 2026 |
PROPEL BIO MANAGEMENT, LLC | 2.51% | 871,460 | -108,238 (-12.42%) | Jun 30, 2026 |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2.34% | 812,561 | -545 (-0.07%) | Jun 30, 2025 |
GEODE CAPITAL MANAGEMENT, LLC | 2.11% | 733,115 | +41,084 (+5.60%) | Jun 30, 2026 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
VANGUARD INDEX FUNDS | 3.44% | 1.2M | -101,642 (-8.51%) | Jun 30, 2026 |
FIDELITY SALEM STREET TRUST | 0.92% | 318,234 | +280,066 (+88.01%) | Jul 31, 2026 |
Simplify Exchange Traded Funds | 0.76% | 264,770 | +3,644 (+1.38%) | Jun 30, 2026 |
North Square Investments Trust | 0.58% | 201,092 | +124,613 (+61.97%) | May 31, 2026 |
VANGUARD SCOTTSDALE FUNDS | 0.53% | 185,488 | +8,767 (+4.73%) | May 31, 2026 |
COLLEGE RETIREMENT EQUITIES FUND | 0.41% | 141,229 | +104,275 (+73.83%) | Jun 30, 2026 |
GuideStone Funds | 0.35% | 122,700 | +122,700 (+100.00%) | Jun 30, 2026 |
Current Ownership Distribution
- Institutions171.8M (78.05%)
- Mutual Funds40.0M (18.17%)
- Insiders8.3M (3.77%)
- Other0 (0.00%)
Insider Transactions
- 3.77% (8.3M)Current InsiderOwnership (%, shares)
- 3Number of InsiderBuying (last 12 months)
- $6.4MAmount of InsiderBuying (last 12 months)
- 0Number of InsiderSelling (last 12 months)
- $0.00Amount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
Rosalind Advisors, Inc. | Conversion | Oct 13, 2026 | $0.00 | 36 | $0.00 | 9,112 |
Rosalind Advisors, Inc. | Conversion | Oct 13, 2026 | $0.00 | 3,627 | $0.00 | 3.4M |
Rosalind Advisors, Inc. | Other | Oct 13, 2026 | $0.00 | 27,502 | $0.00 | 3.4M |
Pennell Sandra Chief Financial Officer | Buy | Mar 06, 2026 | $50,018.32 | 5,533 | $9.04 | 77,018 |
MICHEL GERARD J CHIEF EXECUTIVE OFFICER | Buy | Mar 02, 2026 | $100,309.44 | 11,200 | $8.96 | 342,034 |
Pennell Sandra Chief Financial Officer | Award | Feb 17, 2026 | $0.00 | 56,500 | $0.00 | 56,500 |
Hoffman David L. GEN'L COUNSEL, CCO & SECY | Award | Feb 17, 2026 | $0.00 | 56,500 | $0.00 | 56,500 |
Vukovic Vojo CHIEF MEDICAL OFFICER | Award | Feb 17, 2026 | $0.00 | 56,500 | $0.00 | 56,500 |
Rook Martha S. CHIEF OPERATING OFFICER | Award | Feb 17, 2026 | $0.00 | 56,500 | $0.00 | 56,500 |
MICHEL GERARD J CHIEF EXECUTIVE OFFICER | Award | Feb 17, 2026 | $0.00 | 195,000 | $0.00 | 195,000 |
Hoffman David L. GEN'L COUNSEL, CCO & SECY | Award | Feb 17, 2026 | $0.00 | 28,250 | $0.00 | 28,250 |
Vukovic Vojo CHIEF MEDICAL OFFICER | Award | Feb 17, 2026 | $0.00 | 28,250 | $0.00 | 28,250 |
Muir Kevin GM INTERVENTIONAL ONCOLOGY | Award | Feb 17, 2026 | $0.00 | 56,500 | $0.00 | 56,500 |
Pennell Sandra Chief Financial Officer | Award | Feb 17, 2026 | $0.00 | 28,250 | $0.00 | 28,250 |
Rook Martha S. CHIEF OPERATING OFFICER | Award | Feb 17, 2026 | $0.00 | 28,250 | $0.00 | 28,250 |
MICHEL GERARD J CHIEF EXECUTIVE OFFICER | Award | Feb 17, 2026 | $0.00 | 97,500 | $0.00 | 97,500 |
Muir Kevin GM INTERVENTIONAL ONCOLOGY | Award | Feb 17, 2026 | $0.00 | 28,250 | $0.00 | 28,250 |
Sylvester John Richard | Buy | Nov 21, 2025 | $38,991.54 | 4,386 | $8.89 | 14,936 |
MICHEL GERARD J CHIEF EXECUTIVE OFFICER | Buy | Nov 11, 2025 | $98,049.00 | 11,500 | $8.53 | 330,834 |
Vukovic Vojo CHIEF MEDICAL OFFICER | Exempt | Jun 12, 2025 | $0.00 | 42,000 | $0.00 | 58,500 |
Vukovic Vojo CHIEF MEDICAL OFFICER | Exempt | Jun 12, 2025 | $200,760.00 | 42,000 | $4.78 | 168,882 |
SALAMON STEVEN A J | In The Money | May 05, 2025 | $4.0M | 400,000 | $10.00 | 3.4M |
Rosalind Advisors, Inc. | In The Money | May 05, 2025 | $4.0M | 400,000 | $10.00 | 3.4M |
Aharon Gil | In The Money | May 05, 2025 | $4.0M | 400,000 | $10.00 | 3.4M |
Rook Martha S. CHIEF OPERATING OFFICER | Award | Feb 07, 2025 | $0.00 | 113,000 | $0.00 | 113,000 |
Muir Kevin GM INTERVENTIONAL ONCOLOGY | Award | Feb 07, 2025 | $0.00 | 113,000 | $0.00 | 113,000 |
Pennell Sandra Chief Financial Officer | Award | Feb 07, 2025 | $0.00 | 113,000 | $0.00 | 113,000 |
MICHEL GERARD J CHIEF EXECUTIVE OFFICER | Award | Feb 07, 2025 | $0.00 | 390,000 | $0.00 | 390,000 |
Vukovic Vojo CHIEF MEDICAL OFFICER | Award | Feb 07, 2025 | $0.00 | 113,000 | $0.00 | 113,000 |
Hoffman David L. GEN'L COUNSEL, CCO & SECY | Award | Feb 07, 2025 | $0.00 | 113,000 | $0.00 | 113,000 |